corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 8245

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Kay A.
State of the art. Part 1. Generic medicines
Pharmaceutical Journal 1997 Apr 19; 258:554-559


Abstract:

Various aspects of the generic drug market and of the prescribing and dispensing of generic medications in the United Kingdom (UK) are discussed, including the major participants, new entrants, and attractiveness of the UK generic market, consolidation of pharmaceutical companies, potential effects on the market of the expiration of patents for captopril (Capoten) and ranitidine hydrochloride (Zantac), effects of the Drug Tariff on generic drug costs, exclusivity of clinical drug data in the pharmaceutical industry, patient pack dispensing, and trends in generic prescribing.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








You are going to have many difficulties. The smokers will not like your message. The tobacco interests will be vigorously opposed. The media and the government will be loath to support these findings. But you have one factor in your favour. What you have going for you is that you are right.
- Evarts Graham
See:
When truth is unwelcome: the first reports on smoking and lung cancer.